Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-041613
Filing Date
2021-06-17
Accepted
2021-06-17 17:54:49
Documents
1
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3935
  Complete submission text file 0001209191-21-041613.txt   5317
Mailing Address FLEXION THERAPEUTICS, INC. 10 MALL ROAD, SUITE 301 BURLINGTON MA 01803
Business Address
Canute Scott A (Reporting) CIK: 0001303416 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39575 | Film No.: 211026152

Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Issuer) CIK: 0001671818 (see all company filings)

EIN.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations